LYMRIT 37‐01: UPDATED RESULTS OF A PHASE I/II STUDY OF 177LU‐LILOTOMAB SATETRAXETAN, A NOVEL CD37‐TARGETED ANTIBODY‐ RADIONUCLIDE‐CONJUGATE IN RELAPSED NHL PATIENTS. (June 2017)

• Record Type: Journal Article
• Authors: Kolstad, A.; Madsbu, U.; Beasley, M.; Bayne, M.; Illidge, T.; O'Rourke, N.; Lagerlöf, I.; Hájek, R.; Jurczak, W.; Willenbacher, E.; Blakkisrud, J.; Muftuler Løndalen, A.; Rojkjaer, L.; Baylor Curtis, L.; Bloma, M.; Turner, S.; Bolstad, N.; Spetalen, S.; Erlanson, M.; Nygaard, S.; Holte, H.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 269
• Page End: 270
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_142
• Languages: English
• ISSNs: 0278-0232